Impact of comprehensive family history and genetic analysis in the multidisciplinary pancreatic tumor clinic setting.

Jessica N EverettShenin A DettwylerXiaohong JingCody StenderMadeleine SchmitterAriele BaptisteJennifer ChunEmily A KawalerLauren G KhannaSeth A GrossTamas A GondaNina BeriPaul E ObersteinDiane M Simeone

Published in: Cancer medicine (2022)

Integrating genetics into the multidisciplinary setting significantly improved genetic testing compliance by reducing logistical barriers for PDAC patients, and clarified cancer risks for their relatives while conserving clinical resources. Overall, we identified 206 individuals newly eligible for surveillance or genetic testing (191 relatives of MDPC PDAC patients, and 15 HRI from this cohort), enabling continuity of care for PDAC patients and at-risk relatives in one clinic.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
prognostic factors
primary care
public health
squamous cell carcinoma
palliative care
young adults
squamous cell